Michelle Kwan, Christopher S. Yang, Cuong V. Nguyen
{"title":"Solitary and multiple xanthogranulomas in adult patients: a single-center retrospective cohort study","authors":"Michelle Kwan, Christopher S. Yang, Cuong V. Nguyen","doi":"10.1007/s00403-025-04103-3","DOIUrl":null,"url":null,"abstract":"<div><p>The systemic associations of adult xanthogranulomas (XGs), the most common subtype of non-Langerhans cell histiocytosis, are poorly understood. In this retrospective cohort analysis, we studied adult patients diagnosed with XGs and investigated the clinical features and systemic associations of adult XGs. Among 138 patients (mean age 43.3 years, 51.4% female, 76.8% white), adult XGs most frequently presented on the trunk (40.6%), differing from the pediatric predilection for the head and neck. Patients presenting with multiple XGs (3.6%) were significantly more likely to have systemic malignancies (<i>p</i> = 0.009), particularly hematologic malignancies (<i>p</i> = 0.001), as well as non-malignant hematologic disorders (<i>p</i> = 0.027). Hyperlipidemia (37%), cardiac disease (51.4%), and endocrine disease (31.2%) were the most prevalent systemic comorbidities. In conclusion, the presentation of multiple XGs in an adult is associated with malignancy (particularly hematologic malignancies) and non-malignant hematologic disorders, suggesting a possible link with immune dysregulation. Molecular testing in one patient with multiple XGs and CMML transformed to AML revealed the same KMT2a deletion in both the XGs and the bone marrow, raising the possibility of clonal relationships in some cases.</p></div>","PeriodicalId":8203,"journal":{"name":"Archives of Dermatological Research","volume":"317 1","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Dermatological Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00403-025-04103-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The systemic associations of adult xanthogranulomas (XGs), the most common subtype of non-Langerhans cell histiocytosis, are poorly understood. In this retrospective cohort analysis, we studied adult patients diagnosed with XGs and investigated the clinical features and systemic associations of adult XGs. Among 138 patients (mean age 43.3 years, 51.4% female, 76.8% white), adult XGs most frequently presented on the trunk (40.6%), differing from the pediatric predilection for the head and neck. Patients presenting with multiple XGs (3.6%) were significantly more likely to have systemic malignancies (p = 0.009), particularly hematologic malignancies (p = 0.001), as well as non-malignant hematologic disorders (p = 0.027). Hyperlipidemia (37%), cardiac disease (51.4%), and endocrine disease (31.2%) were the most prevalent systemic comorbidities. In conclusion, the presentation of multiple XGs in an adult is associated with malignancy (particularly hematologic malignancies) and non-malignant hematologic disorders, suggesting a possible link with immune dysregulation. Molecular testing in one patient with multiple XGs and CMML transformed to AML revealed the same KMT2a deletion in both the XGs and the bone marrow, raising the possibility of clonal relationships in some cases.
期刊介绍:
Archives of Dermatological Research is a highly rated international journal that publishes original contributions in the field of experimental dermatology, including papers on biochemistry, morphology and immunology of the skin. The journal is among the few not related to dermatological associations or belonging to respective societies which guarantees complete independence. This English-language journal also offers a platform for review articles in areas of interest for dermatologists and for publication of innovative clinical trials.